Motivated by their findings, we simultaneously investigated the spatial heterogeneity in the TME cellular composition of CD14+ cells, CD19+ B cells, CD4+ and CD8+ T cells, and CK+ tumor cells, and their collective impact on the overall survival. The gene discussed is CD4; the disease is neoplasm.